FR144420
FR144420 (NOR4) is an orally active nitric oxide (NO) -releasing agent with vasodilatory and antiplatelet effects. FR144420 induces cGMP-mediated vasodilation and inhibits platelet aggregation. FR144420 is promising for research of cardiovascular diseases, particularly angina pectoris and coronary artery spasm[1].
Product Specifications
CAS Number
162626-99-5
Product Name Alternative
NOR4
UNSPSC
12352005
Hazard Statement
H315-H319-H335
Target
NO Synthase
Related Pathways
Immunology/Inflammation
Field of Research
Cardiovascular Disease
Smiles
O=C(C1=CC=CN=C1)NCC(/C=C(CC)/C([N+]([O-])=O)C)=N\O
Molecular Formula
C14H18N4O4
Molecular Weight
306.32
Precautions
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P362+P364-P403+P233-P405-P501
References & Citations
[1]Hirasawa Y, et al. Antianginal effects of FR144420, a novel slow nitric oxide-releasing agent. Eur J Pharmacol. 1996 May 6;303 (1-2) :55-9.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
SAR1B (GTP Binding Protein SAR1b, ANDD, CMRD, GTBPB, SARA2) discontinued
SAR1B (GTP Binding Protein SAR1b, ANDD, CMRD, GTBPB, SARA2) discontinued
